False negatives reported from new COVID-19 strain

NCPA January 11, 2021

FDA warns that genetic variants of SARS-CoV-2 may lead to false negative results. Pharmacies should note that one of the three tests listed at this time is the CLIA-waived Accula SARS-CoV-2 test. Information on surveillance for this strain is available from the CDC.

NCPA